Omni Star Financial Group, Inc. Gilead Sciences, Inc. Transaction History
Omni Star Financial Group, Inc.
- $122 Million
- Q2 2025
A detailed history of Omni Star Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 14,956 shares of GILD stock, worth $1.83 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
14,956
Previous 12,259
22.0%
Holding current value
$1.83 Million
Previous $1.37 Million
20.76%
% of portfolio
1.36%
Previous 1.19%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,352Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.22 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.65 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.58 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $153B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...